Effects of chronic opiate and opioid antagonist treatment on striatal opioid peptides

Brain Research
K A TrujilloH Akil

Abstract

It has long been speculated that feedback inhibition of endogenous opioid neurons may have a role in opiate tolerance and dependence. However, in studies in which opiates or opioid antagonists have been administered to animals, mixed results have been obtained on the ability of these drugs to regulate endogenous opioids. The present studies were undertaken to determine the effects of chronic administration of opiate drugs on opioid peptides. These studies focused on the regulation of prodynorphin (Prodyn) and proenkephalin (Proenk) peptides in striatal tissue. Morphine, whether administered by chronic infusion or repeated injection, was found to increase the concentration of Prodyn peptides in striatum. Increases were statistically significant in the sensorimotor dorsal striatum (caudate-putamen) but not in the limbic-motor ventral striatum (nucleus accumbens-olfactory tubercle). No changes in Prodyn peptides were found following chronic administration of the opioid antagonist naltrexone. No changes in the Proenk peptide MERGL were found following chronic treatment with morphine or naltrexone. These studies are consistent with the suggestion that Prodyn neurons may have a role in the consequences of long-term opiate administrat...Continue Reading

References

Sep 1, 1976·The British Journal of Addiction to Alcohol and Other Drugs·J Hughes
Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A GoldsteinL Hood
Jan 15, 1979·Biochemical and Biophysical Research Communications·K Kangawa, H Matsuo
May 1, 1979·Neuroscience Letters·J ShaniB A Weissman
Dec 1, 1977·European Journal of Pharmacology·S R ChildersS H Snyder
Dec 20, 1979·European Journal of Pharmacology·L Bergström, L Terenius
Jul 1, 1975·Life Sciences·H W Kosterlitz, J Hughes
Sep 17, 1976·Science·A Goldstein
Aug 5, 1976·Nature·R Simantov, S H Snyder
Apr 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·C H Li, D Chung
Jun 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·B M CoxC H Hi
Nov 1, 1992·Brain Research. Molecular Brain Research·Y L Hurd, M Herkenham
Mar 1, 1992·Brain Research. Molecular Brain Research·Y L HurdC R Gerfen
May 1, 1992·Pharmacology, Biochemistry, and Behavior·T L PierceJ E Olley
Jul 1, 1990·Neuropharmacology·J M FujimotoL F Tseng
Jan 1, 1989·Neuroscience and Biobehavioral Reviews·G F KoobF E Bloom
Jul 2, 1987·European Journal of Pharmacology·B A Weissman, N Zamir
Oct 11, 1988·European Journal of Pharmacology·G R HansonJ W Gibb
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Jan 29, 1981·European Journal of Pharmacology·H J FriedmanH H Loh
Dec 10, 1982·Science·J M WalkerH Akil
Oct 1, 1982·Pharmacological Research Communications·W K HoH L Wen
Jan 1, 1984·Progress in Neuro-psychopharmacology & Biological Psychiatry·M R Peterson, H A Robertson
Jan 1, 1984·Annual Review of Neuroscience·D E Redmond, J H Krystal
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A TempelR S Zukin

❮ Previous
Next ❯

Citations

Mar 30, 1999·Brain Research. Molecular Brain Research·X M WangM J Kreek
Jan 1, 1996·Peptides·G A OlsonA J Kastin
Oct 7, 2004·European Journal of Pharmacology·Ryszard Przewlocki
Jul 19, 2013·Journal of Psychopharmacology·Mark J Hunt, Stefan Kasicki
Jan 27, 2005·Neurochemistry International·G LarrinagaJ Irazusta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.